References
- Huang KE, Davis SA, Cantrell J, Feldman SR. Increasing use of non-traditional vehicles for psoriasis and other inflammatory skin conditions. Dermatol Online J. 2014;20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25244174
- Kimball AB, Gold MH, Zib B, Davis MW. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. J Am Acad Dermatol. 2008;59:448–55.
- FDA. CLOBEX spray full prescribing information. NDA 021835/S-006. October, 2012.
- Review Letter IND 101789 Desoximetasone Spray, 0.25%. Center for Drug Evaluation and Research, Division of Dermatology and Dental Products July, 2009.